{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:32:09Z","timestamp":1761766329371},"reference-count":39,"publisher":"SLACK, Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>\n            The current research evaluated metabolic side effects in inpatients (\n            <jats:italic>N<\/jats:italic>\n            = 271) using atypical antipsychotic medications in a psychiatric hospital in Turkey between June and December 2016. Data were collected via an information form created after reviewing the literature at the time of patients' hospitalization and discharge. According to the analysis, 73.8% of patients stated they experienced side effects from antipsychotic medications and 20.7% of patients experienced weight gain. A statistical difference was detected among body mass index, waist circumference, diastolic blood pressure, and heart rate during patient hospitalization and discharge. Patients using atypical anti-psychotic medications gained weight, had increased cardiovascular risk, and experienced adverse effects on their physical health during hospitalization. Mental health nurses should inform patients of medication effects and possible side effects, monitor side effects, and teach patients how to manage metabolic side effects. [\n            <jats:italic>Journal of Psychosocial Nursing and Mental Health Services, 56<\/jats:italic>\n            (4), 28\u201337.]\n          <\/jats:p>","DOI":"10.3928\/02793695-20180108-05","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T13:58:55Z","timestamp":1515765535000},"page":"28-37","source":"Crossref","is-referenced-by-count":9,"title":["Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization"],"prefix":"10.3928","volume":"56","author":[{"given":"G\u00fcl","family":"Dike\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla Baysan","family":"Arabaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl\u00e7in B\u00f6l\u00fck","family":"Uzunoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin Demet","family":"Mizrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2007.04.011"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-57"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1121-1"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12195"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-87"},{"key":"e_1_3_1_8_1","article-title":"Metabolic and endocrine side effects of atypical antipsychotic drugs in children and adolescents [article in Turkish]","volume":"3","author":"\u00c7elik G.G.","year":"2011","unstructured":"\u00c7elik G.G., Tahiroglu A., Avci A. (2011). Metabolic and endocrine side effects of atypical antipsychotic drugs in children and adolescents [article in Turkish]. Psikiyatride G\u00fcncel Yaklasimla, 3.","journal-title":"Psikiyatride G\u00fcncel Yaklasimla"},{"key":"e_1_3_1_9_1","first-page":"124","article-title":"The prevalence of metabolic syndrome and related factors in patients with schizophrenia [article in Turkish]","volume":"19","author":"Cerit C.","year":"2008","unstructured":"Cerit C., Ozten E., Yildiz M. (2008). The prevalence of metabolic syndrome and related factors in patients with schizophrenia [article in Turkish]. Turk Psikiyatri Dergisi, 19, 124\u2013132.","journal-title":"Turk Psikiyatri Dergisi"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.5455\/cap.20140527123634"},{"issue":"2","key":"e_1_3_1_11_1","first-page":"13","article-title":"Metabolic syndrome prevalence in a group of patients with schizophrenia using atypical antipsychotic [article in Turkish]","volume":"3","author":"Demirel A.","year":"2013","unstructured":"Demirel A., Demirel O.F., Ugur M., Kadak A. (2013). Metabolic syndrome prevalence in a group of patients with schizophrenia using atypical antipsychotic [article in Turkish]. G\u00fcncel Psikiyatri ve Psikon\u00f6rofarmakoloji, 3(2), 13\u201320.","journal-title":"G\u00fcncel Psikiyatri ve Psikon\u00f6rofarmakoloji"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-12-20"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.5505\/phd.2015.69875"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp115"},{"key":"e_1_3_1_15_1","first-page":"167","article-title":"Schizophrenia, atypical antipsychotics, and obesity [article in Turkish]","volume":"7","author":"Eraslan D.","year":"2006","unstructured":"Eraslan D., \u00d6zt\u00fcrk \u00d6., Kayahan B., Zorlu N., Veznedaroglu B. (2006). Schizophrenia, atypical antipsychotics, and obesity [article in Turkish]. Anadolu Psikiyatri Dergisi, 7, 167\u2013172.","journal-title":"Anadolu Psikiyatri Dergisi"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-157"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.08.010"},{"key":"e_1_3_1_18_1","first-page":"67","article-title":"The frequency of metabolic syndrome in schizophrenia patients using antipsychotic medication and related factors","volume":"49","author":"G\u00fcveli H.","year":"2011","unstructured":"G\u00fcveli H., Cem Ilnem M., Yener F., Karamustafalioglu N., Ipek\u00e7ioglu D., Abanoz Z. (2011). The frequency of metabolic syndrome in schizophrenia patients using antipsychotic medication and related factors. New Yeni Symposium Journal, 49, 67\u201376.","journal-title":"New Yeni Symposium Journal"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S42735"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/09638237.2012.759194"},{"key":"e_1_3_1_21_1","unstructured":"International Diabetes Foundation. (2006). IDF consensus worldwide definition of the metabolic syndrome . Retrieved from https:\/\/www.idf.org\/e-library\/consensus-statements\/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.10.1079"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v06n0205"},{"key":"e_1_3_1_24_1","first-page":"13","article-title":"Prevalence of metabolic syndrome, characteristics of metabolic syndrome and relationship with the antipsychotics used in schizophrenia [article in Turkish]","volume":"46","author":"Kaya M.C.","year":"2009","unstructured":"Kaya M.C., Virit O., Altindag A., Selek S., B\u00fclb\u00fcl F., Bulut M., Savas H.A. (2009). Prevalence of metabolic syndrome, characteristics of metabolic syndrome and relationship with the antipsychotics used in schizophrenia [article in Turkish]. Noropsikiatri Arsivi, 46, 13\u201319.","journal-title":"Noropsikiatri Arsivi"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11010039"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.07.014"},{"key":"e_1_3_1_28_1","first-page":"168","article-title":"Metabolic side effects of new agent antipsychotics [article in Turkish]","volume":"14","author":"Mete L.","year":"2004","unstructured":"Mete L., \u00dcnsal P.\u00c7. (2004). Metabolic side effects of new agent antipsychotics [article in Turkish]. Klinik Psikofarmakoloji Bulteni, 14, 168\u2013177.","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.4.630"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002066"},{"key":"e_1_3_1_31_1","first-page":"55","article-title":"Therapeutic milieu in a psychiatric ward and the responsibilities of nurses [article in Turkish]","volume":"7","author":"Oflaz F.","year":"2006","unstructured":"Oflaz F. (2006). Therapeutic milieu in a psychiatric ward and the responsibilities of nurses [article in Turkish]. Anadolu Psikiyatri Dergisi, 7, 55\u201361.","journal-title":"Anadolu Psikiyatri Dergisi"},{"key":"e_1_3_1_32_1","first-page":"26","article-title":"The frequency of metabolic syndrome in patients with schizophrenia and schizoaffective disorder [article in Turkish]","volume":"10","author":"\u00d6yek\u00e7in D.G.","year":"2009","unstructured":"\u00d6yek\u00e7in D.G. (2009). The frequency of metabolic syndrome in patients with schizophrenia and schizoaffective disorder [article in Turkish]. Anadolu Psikiyatri Dergisi, 10, 26\u201333.","journal-title":"Anadolu Psikiyatri Dergisi"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0349.2012.00883.x"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.07.012"},{"key":"e_1_3_1_35_1","first-page":"80","article-title":"Metabolic syndrome in schizophrenia and schizoaffective disorder [article in Turkish]","volume":"15","author":"Songur E.","year":"2012","unstructured":"Songur E., Karslioglu E.H., Soyg\u00fcr H., Kaymak S.U., \u00d6zalp E., Cankurtaran E.S. (2012). Metabolic syndrome in schizophrenia and schizoaffective disorder [article in Turkish]. Klinik Psikiyatri Dergisi, 15, 80\u201391.","journal-title":"Klinik Psikiyatri Dergisi"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.3.428"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpm.12300"},{"key":"e_1_3_1_38_1","first-page":"251","article-title":"Cardiovascular side effects of antipsychotic medications [article in Turkish]","volume":"1","author":"Yagcioglu A.E.","year":"2011","unstructured":"Yagcioglu A.E., Ertugrul A. (2011). Cardiovascular side effects of antipsychotic medications [article in Turkish]. Psikiyatride G\u00fcncel, 1, 251\u2013265.","journal-title":"Psikiyatride G\u00fcncel"},{"key":"e_1_3_1_39_1","first-page":"147","article-title":"The reliability of Turkish form of Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) [article in Turkish]","volume":"16","author":"Yilmaz S.","year":"2006","unstructured":"Yilmaz S., Buzlu S. (2006). The reliability of Turkish form of Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) [article in Turkish]. Klinik Psikofarmakoloji Bulteni, 16, 147\u2013154.","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"key":"e_1_3_1_40_1","first-page":"5","article-title":"Metabolic side effects because of antipsychotics [article in Turkish]","volume":"9","author":"Y\u00fcksel N.","year":"2006","unstructured":"Y\u00fcksel N., Sayin A. (2006). Metabolic side effects because of antipsychotics [article in Turkish]. Klinik Psikiyatri Dergisi, 9, 5\u201316.","journal-title":"Klinik Psikiyatri Dergisi"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.healio.com\/doiresolver?doi=10.3928\/02793695-20180108-05","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:30:46Z","timestamp":1683088246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20180108-05"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.3928\/02793695-20180108-05"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20180108-05","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}